Loading...
TLR9 deficiency alleviates doxorubicin‐induced cardiotoxicity via the regulation of autophagy
Doxorubicin is a commonly used anthracycline chemotherapeutic drug. Its application for treatment has been impeded by its cardiotoxicity as it is detrimental and fatal. DNA damage, cardiac inflammation, oxidative stress and cell death are the critical links in DOX‐induced myocardial injury. Previous...
Saved in:
| Published in: | J Cell Mol Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7521247/ https://ncbi.nlm.nih.gov/pubmed/33140921 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.15719 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|